Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-04-30 | Dr. Rowinsky has extensive research and drug development experience, oncology expertise, and broad scientific and medical knowledge. |
| 2016-04-15 | Dr. Rowinsky has extensive research and drug development experience, oncology expertise, and broad scientific and medical knowledge. |
| 2017-04-26 | Dr. Rowinsky has extensive research and drug development experience, oncology expertise, and broad scientific and medical knowledge. |
| 2018-04-27 | Dr. Rowinsky has extensive research and drug development experience and broad scientific and medical knowledge. |
| 2019-04-30 | Dr. Rowinsky has extensive research and drug development experience and broad scientific and medical knowledge. |
| 2020-04-20 | Dr. Rowinsky has extensive research and drug development experience and broad scientific and medical knowledge. |
| 2021-04-23 | Dr. Rowinsky has extensive research and drug development experience and broad scientific and medical knowledge. |
| 2022-04-29 | Dr. Rowinsky has extensive research and drug development experience and broad scientific and medical knowledge. |
| 2023-04-28 | Dr. Rowinsky has extensive research and drug development and regulatory experience and broad scientific and medical knowledge. |
| 2024-04-26 | Dr. Rowinsky has extensive research and drug development and regulatory experience and broad scientific and medical knowledge. Education: B.A. in Liberal Arts from New York University, M.D. from Vanderbilt University School of Medicine. |
Data sourced from SEC filings. Last updated: 2025-08-30